Replimune Group Inc

Replimune Group Inc

REPL

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.01B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Replimune Group IncReplimune Group Inc-3.6--189%-0.2
$15.50

Target Price by Analysts

28.5% upsideReplimune Group Target Price DetailsTarget Price
$1.05

Current Fair Value

91.3% downside

Overvalued by 91.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.01 Billion
Enterprise Value$832.61 Million
Dividend Yield$- (-)
Earnings per Share$-3.38
Beta0.87
Outstanding Shares92,803,711

Return

Return on Equity-188.94%ROE
Return on Assets-94.45%
Return on Invested Capital-113.40%

Valuation & Multiples

P/E Ratio-3.57P/E Ratio
PEG289.7PEG
Price to Sales-Price to Sales
Price to Book Ratio12.06Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-2.68
Enterprise Value to Net Income-3
Total Debt to Enterprise0.03
Debt to Equity0.17Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 6, 2026
EPS Estimate
$-0.69
Average shareholder expectation
Revenue Estimate
$13.60 M
Average shareholder expectation

Next Earnings Call

Expected Date
October 29, 2026
EPS Estimate
$-0.64
Average shareholder expectation
Revenue Estimate
$800,000
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio9.9610 964.76%
Total Calls32,274 99.42%
Total Puts321,480 81.61%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %18.26% 69.71%
Total Invested$187.92M 69.65%
Investors Holding77 130.00%

ESG Score

No data

About Replimune Group Inc

CEO: Robert Coffin